From: Cardiometabolic risk indicators in individuals with bipolar disorders: a replication study
CMRIs | Patients (n = 407) | Controls (n = 56) | T-test | Linear regression (adjusted for age and sex) | ||
---|---|---|---|---|---|---|
Mean difference (95% CI) | P-value | Coefficient estimate | P-value | |||
WHR, mean ± SD | 0.88 ± 0.08 | 0.89 ± 0.07 | − 0.01 (− 0.03–0.01) | 0.2 | 0.003 | > 0.30 |
BMI, mean ± SD, kg/m2 | 26.9 ± 5.9 | 24.9 ± 3.6 | 2.1 (0.9–3.2) | < 0.001 | 0.14 | 0.003 |
SBP, mean ± SD, mm Hg | 124.2 ± 14.4 | 126.2 ± 10.3 | − 1.9 (− 5.1–1.1) | 0.2 | − 0.003 | > 0.30 |
DBP, mean ± SD, mm Hg | 76.8 ± 9.3 | 80.3 ± 8.7 | − 3.4 (− 6.0 – − 0.9) | 0.009 | − 0.09 | 0.05 |
TAG, mean ± SD, mmol/L | 1.1 ± 0.9 | 1.0 ± 0.5 | 0.1 (− 0.1–0.3) | 0.2 | 0.06 | 0.2 |
TAG/HDL-C ratio, mean ± SD | 0.9 ± 1.5 | 0.7 ± 0.6 | 0.2 (− 0.2–0.6) | > 0.30 | 0.06 | 0.2 |
TChol/HDL-C ratio, mean ± SD | 3.6 ± 2.1 | 3.5 ± 1.5 | 0.2 (− 0.4–0.7) | > 0.30 | 0.04 | > 0.30 |
Non-HDL-C, mean ± SD, mmol/L | 3.5 ± 1.0 | 3.6 ± 1.0 | − 0.1 (− 0.4–0.2) | > 0.30 | − 0.005 | > 0.30 |